[ @entity208 -induced DRESS complicated by XXXX ].

@entity1712 @entity1 @entity2298 @entity137 @entity2176 @entity1910 @entity9058 @entity4 @entity56 @entity109 @entity7586 @entity236 @entity208 @entity2812 @entity2753
BACKGROUND: Drug @entity7586 is among the most severe @entity56 and in rare cases it may progress to @entity9058 . Herein, we report a case of @entity208 -induced @entity137 with @entity1712 and systemic symptoms complicated by @entity9058 . CASE REPORT: An 18-year-old @entity1 presented with maculopapular @entity1910 associated with cervical lymphadenopahy appearing 3 weeks after treatment with @entity208 . Her hemodynamic status at admission was unstable. Cutaneous examination revealed an itchy maculopapular @entity1910 , which was purpuric at certain sites, together with @entity4 . The diagnosis of @entity56 was suggested and was confirmed by histological examination of a skin biopsy. @entity208 was stopped. Two weeks later, however, @entity1712 was noted. Further, four days after discontinuation of @entity208 , in view of the laboratory signs of bicytopenia, @entity2753 , @entity2298 and hyperferritinaemia, as well as the presence of hemophagocytosis in @entity236 , a diagnosis was made of @entity9058 complicating a @entity137 with @entity1712 and systemic symptoms. Moreover, viral serology tests were negative. The @entity1 was given intravenous immunoglobulin and the outcome was good. DISCUSSION: The literature contains only very few reports of @entity137 with @entity1712 and systemic symptoms complicated by @entity9058 . The incriminated drugs were @entity2176 , @entity2812 and @entity109 . To our knowledge, there has only been one report of @entity208 -induced @entity137 with @entity1712 and systemic symptoms complicated by @entity9058 .
